Uterine myoma is the most common benign tumors of the uterus and may be presented 20-40% of women at reproductive age [1]. The myomas can be asymptomatic. However, they often cause abnormal uterine bleeding, pelvic pain, compression symptom, or even infertility [1,2]. Instead of hysterectomy, myomectomy can be one option for symptomatic women who wish to preserve their childbearing capabilities [3,4]. Along with advances and
Peritoneal recurrence of advanced ovarian cancer is a substantial problem. Early detection is essential for timely treatment. Computed tomography is an excellent tool for follow-up; however, it has limitations. Positron emission tomography (PET) detects recurrent lesions by virtue of its superior image resolution. Few recorded cases reported the role of minimally invasive procedures in isolated recurrent ovarian cancer. Herein, we document a perihepatic recurrence of ovarian carcinoma successfully managed with robotic resection. This patient had stage IIIC ovarian cancer sensitive to chemotherapy (paclitaxel and carboplatin), and was followed-up with PET. The patient underwent robotic resection of limited recurrent cancer. For recurrent ovarian cancer, cytoreductive operations are recommended for platinum-sensitive tumors. Robotic-assisted surgery has been widely used since 2005 and is becoming increasingly popular. Its popularity is attributed to its being a delicate surgical technique has substantially lower blood loss and surgery time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.